Mohd Mursal , Arun Kumar , Syed Misbahul Hasan , Sahil Hussain , Kuldeep Singh , Shom Prakash Kushwaha , Muhammad Arif , Rajeev Kumar Singh , Deepshikha Singh , Ali Mohammad , Syed Kaynat Fatima
{"title":"Role of natural bioactive compounds in the management of neurodegenerative disorders","authors":"Mohd Mursal , Arun Kumar , Syed Misbahul Hasan , Sahil Hussain , Kuldeep Singh , Shom Prakash Kushwaha , Muhammad Arif , Rajeev Kumar Singh , Deepshikha Singh , Ali Mohammad , Syed Kaynat Fatima","doi":"10.1016/j.ipha.2023.09.006","DOIUrl":"10.1016/j.ipha.2023.09.006","url":null,"abstract":"<div><p>Lately, substantial exploration and study have focused on natural products, along with their bioactive compounds. Neurodegenerative diseases (NDDs) such as Alzheimer's disease (AD), Huntington's disease (HD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS) involve progressive neural breakdown and cell loss, culminating in neuronal death. The brain is susceptible to various forms of stress, particularly oxidative stress (OS) caused by the body's oxygen requirements and utilization. The vulnerability of the brain is heightened by the significant presence of unsaturated fatty acids. To gain accurate insights into NDD, various factors such as genetics and environmental risks must be considered, as they can reduce the effectiveness of therapies for NDDs. Addressing oxidative damage and discovering safe and efficient treatments for NDDs are crucial objectives. In this pursuit, bioactive compounds play a vital role in research. Among these compounds, natural elements such as carotenoids, essential oils, essential fatty acids, polyphenols, and phytosterols are captivating due to their potent antioxidant and anti-inflammatory traits. These qualities hold the potential for enhancing brain health. This review centers on assessing how these bioactive compounds can bolster the brain's limited antioxidant and regenerative abilities, foster neurogenesis, offer neuroprotection, and mitigate NDDs.</p></div>","PeriodicalId":100682,"journal":{"name":"Intelligent Pharmacy","volume":"2 1","pages":"Pages 102-113"},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2949866X23000825/pdfft?md5=6ea1dad0eab11472934d4f708294c06c&pid=1-s2.0-S2949866X23000825-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135348573","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
MD Ismail Ahmed Fahim, Tamanna Shahrin Tonny, Abdullah Al Noman
{"title":"Realizing the potential of AI in pharmacy practice: Barriers and pathways to adoption","authors":"MD Ismail Ahmed Fahim, Tamanna Shahrin Tonny, Abdullah Al Noman","doi":"10.1016/j.ipha.2024.02.003","DOIUrl":"https://doi.org/10.1016/j.ipha.2024.02.003","url":null,"abstract":"","PeriodicalId":100682,"journal":{"name":"Intelligent Pharmacy","volume":"55 23","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139880803","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Synthesis of 1,3-substituted 1H-indazole derivatives and evaluation of anti-inflammatory activity in Sprague Dawley rats","authors":"Vishal Kumar , Anup Kumar Sirbaiya , Md Nematullah , Md Faheem Haider , Md Azizur Rahman","doi":"10.1016/j.ipha.2023.09.009","DOIUrl":"10.1016/j.ipha.2023.09.009","url":null,"abstract":"<div><p>Indazole is a very significant group of heterocyclics. Aim of the research was thus planned to synthesize novel derivatives of indazole and evaluate their anti-inflammatory activity. Novel compounds of indazole were first synthesized from reaction of 2-chlorobenzonitrile with phenylhydrazine in presence of catalyst potassium <em>t</em>-butoxide (<em>t</em>-BuOK) and the solvent diglyme. Synthesized derivatives of indazole were analyzed by <sup>1</sup><em>H</em>-NMR and MS spectroscopic techniques. All the synthesized derivatives of indazole were evaluated for their anti-inflammatory activity in Sprague Dawley rats by carrageenan-induced rat paw edema method. All the synthesized derivatives of indazole had shown very good activity in both docking and anti-inflammatory activity in rats in comparison to the standard etoricoxib. Compound <strong>1a</strong> in a dose of 30 mg/kg body weight had shown most significant inhibition of edema as compared to toxic group and the inhibition was comparable to that of the standard drug, etoricoxib in a dose of 10 mg/kg body weight. A convenient means for the synthesis of derivatives of indazole was developed which may find applications in heterocyclic synthesis of derivatives of indazole. Compound <strong>1a</strong> i.e., 3-(4-carboxyphenyl)amino-1-phenyl-1<em>H</em>-indazole had shown best anti-inflammatory activity amongst all the synthesized compounds.</p></div>","PeriodicalId":100682,"journal":{"name":"Intelligent Pharmacy","volume":"2 1","pages":"Pages 40-44"},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2949866X23000850/pdfft?md5=e235c2bc500cfb3fbfb7fb05fea4f757&pid=1-s2.0-S2949866X23000850-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134918285","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Artificial intelligence in anti-dengue drug development","authors":"M. Roney","doi":"10.1016/j.ipha.2024.01.006","DOIUrl":"https://doi.org/10.1016/j.ipha.2024.01.006","url":null,"abstract":"","PeriodicalId":100682,"journal":{"name":"Intelligent Pharmacy","volume":"21 6","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139880603","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Priyanka Bajpai, S. Usmani, Rakesh Kumar, Om Prakash
{"title":"Recent advances in anticancer approach of traditional medicinal plants: A novel strategy for cancer chemotherapy","authors":"Priyanka Bajpai, S. Usmani, Rakesh Kumar, Om Prakash","doi":"10.1016/j.ipha.2024.02.001","DOIUrl":"https://doi.org/10.1016/j.ipha.2024.02.001","url":null,"abstract":"","PeriodicalId":100682,"journal":{"name":"Intelligent Pharmacy","volume":"69 7","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139873111","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Hema Jaiswal , Mohammad Tahir Ansari , Tarique Mahmood , Farogh Ahsan , Vaseem Ahamad Ansari , Usama Ahmad
{"title":"Aceclofenac loaded microspheres: Formulation and evaluation of novel preprogrammed drug delivery for the treatment of arthritis","authors":"Hema Jaiswal , Mohammad Tahir Ansari , Tarique Mahmood , Farogh Ahsan , Vaseem Ahamad Ansari , Usama Ahmad","doi":"10.1016/j.ipha.2023.10.010","DOIUrl":"10.1016/j.ipha.2023.10.010","url":null,"abstract":"<div><p>Arthritis is a widespread joint disorder globally, the patient completely dependent on NSAIDs which are administered after a fixed interval to subside the pain. This work aims to establish a preprogrammed drug delivery system of aceclofenac with a predetermined lag time for the treatment of arthritis. This new preprogrammed formulation microsphere reduces the time-dependent dose administration as it steadily releases the drug in the blood circulation reducing side effects and increasing patient compliance. Aceclofenac (ACF) loaded polymer microspheres were prepared by a new emulsification and crosslinking method using glutaraldehyde as cross-linking agent. Microspheres were prepared in 6 batches using different polymers like sodium alginate, guar gum and chitosan, alone, as well as in combinations. The type and quantity of polymers were changed in every batch while the amount of aceclofenac was unvarying. The microspheres were then evaluated for the particle size, drug content, percentage yield, percentage entrapment efficiency and percentage drug release followed by noting the lag time. The microsphere loaded with aceclofenac were formulated and evaluated, the result showed that all the preparations showed a good lag time (2–3 h), but chitosan (alone) gave the highest lag time, which fulfills the aim of pre-programmed drug delivery system. Preprogrammed drug release has been achieved from the microspheres over a period of 0–7 h, consistent with the demand for chronotherapeutic drug delivery for the treatment of arthritis. The major signification of the preparation technique includes short processing time and the lack of exposure of the ingredients to high temperatures. Aceclofenac-loaded microspheres offer a promising avenue for arthritis treatment, ensuring sustained drug release. Their potential clinical implications include enhanced therapeutic efficacy, reduced side effects, and improved patient compliance. Future directions may involve personalized formulations, targeted delivery systems, and exploring applications beyond arthritis, expanding the scope of this innovative drug delivery approach.</p></div>","PeriodicalId":100682,"journal":{"name":"Intelligent Pharmacy","volume":"2 1","pages":"Pages 69-82"},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2949866X23001016/pdfft?md5=2acb88de8cb2027b64b4d3858b16868f&pid=1-s2.0-S2949866X23001016-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135372139","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"An aqueous extract of Syzygium cumini bark reduces the rate of preterm birth in rats","authors":"M. Ramasamy , Karthikeyan E","doi":"10.1016/j.ipha.2023.09.004","DOIUrl":"10.1016/j.ipha.2023.09.004","url":null,"abstract":"<div><p>Preterm delivery is a considerable burden on prenatal healthcare and a major risk factor for neurological impairment and disability. A study looked at whether an aqueous extract of <em>Syzygium cumini</em> (AESC) bark could stop rats from giving birth too early. The DPPH and ABTS radical scavenging assays were used to evaluate the antioxidant activity of AESC in vitro, and the results showed that this extract possesses free radical scavenging activity, which helps to prevent premature labour. A piece of an isolated rat uterus was used for in-vitro pharmacological testing of the AESC at 25 mg/ml and 50 mg/ml. The extract showed free radical scavenging activity, effectively suppressing uterine contractions by 45.7% and 66.9%, respectively. The researchers concluded that AESC has considerable tocolytic activity, resulting in a decrease in the rate of premature birth. The extract showed no significant adverse effects on mothers or their infants, suggesting it may be a safe option for pregnant individuals seeking to prevent preterm labor. The extract also exhibited a dose-dependent effect, with higher doses resulting in a greater reduction in premature birth rates, further supporting its efficacy as a tocolytic agent.</p></div>","PeriodicalId":100682,"journal":{"name":"Intelligent Pharmacy","volume":"2 1","pages":"Pages 136-143"},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2949866X23000801/pdfft?md5=b4d65d8a3c779869f3e5e52ac804bd50&pid=1-s2.0-S2949866X23000801-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135433951","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Parvej Ahmad , Sahir Sultan Alvi , Inamul Hasan , M. Salman Khan
{"title":"Targeting SARS-CoV-2 main protease (Mpro) and human ACE-2: A virtual screening of carotenoids and polyphenols from tomato (Solanum lycopersicum L.) to combat Covid-19","authors":"Parvej Ahmad , Sahir Sultan Alvi , Inamul Hasan , M. Salman Khan","doi":"10.1016/j.ipha.2023.10.008","DOIUrl":"10.1016/j.ipha.2023.10.008","url":null,"abstract":"<div><h3>Background</h3><p>Human angiotensin-converting enzyme-2 (ACE-2) and severe acute respiratory syndrome corona virus-2 (SARS-CoV-2) main protease (M<sup>pro</sup>) have been established as the prime targets to restrict viral invasion and replication inside the host, respectively.</p></div><div><h3>Methods</h3><p>The current study delineated the SARS-CoV-2 M<sup>pro</sup> as well as human ACE-2 inhibitory potential of carotenoids and polyphenols from tomato (<em>Solanum lycopersicum</em> L.) via <em>in-silico</em> interaction studies.</p></div><div><h3>Results</h3><p>Our drug-likeness studies showed that the selected carotenoids and polyphenols exhibited acceptable Lipinski’s score and ADME determinants. Further, i<em>n-silico</em> molecular modelling studies revealed that β-carotene, among other carotenoids, topped the binding score (ΔG: −6.75 kcal/mol; K<em>i</em>: 11.32 μM) against SARS-CoV-2 M<sup>pro</sup>, whereas, cyanidin was the best inhibitor of SARS-CoV-2 M<sup>pro</sup> (−7.24 kcal/mol; K<em>i</em>: 4.92 μM) amongst polyphenols. Similarly, α-carotene from carotenoids exhibited strongest human ACE-2 inhibitory activity (ΔG: −8.85 kcal/mol; K<em>i</em>: 326.13 μM), whereas, cyanidin from polyphenols showed best binding affinity against human ACE-2 (ΔG: −7.24 kcal/mol; K<em>i</em>: 4.89 μM). In contrast, 6-(ethylamino)-pyridine-3-carbonitrile, standard inhibitor of SARS-CoV-2 M<sup>pro</sup>, exhibited comparatively weaker binding (ΔG: −4.78 kcal/mol; K<em>i</em>: 267.49 μM), whereas, telmisartan (reference ACE-2 inhibitor) also exhibited lesser affinity (ΔG: −6.40 kcal/mol; K<em>i</em>: 20.40 μM). Further exploration via MDS studies also validated the dynamic behavior and stability of protein-ligand complexes as evident by desirable RMSD, RMSF, Rg, and SASA.</p></div><div><h3>Conclusion</h3><p>The current study established carotenoids and polyphenols from <em>S. lycopersicum</em> L. as finer substitutes of reference standards against SARS-CoV-2 M<sup>pro</sup> and human ACE-2 activity in combating SARS-CoV-2 infection.</p></div>","PeriodicalId":100682,"journal":{"name":"Intelligent Pharmacy","volume":"2 1","pages":"Pages 51-68"},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2949866X23000990/pdfft?md5=1f5af69ec4a7f39b64b5e5511912de3d&pid=1-s2.0-S2949866X23000990-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136056562","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Ziziphus mauritiana: An in-depth review of its medicinal attributes and pharmacological activities","authors":"Deepak Jha , Pallavi Hangargekar , Md Akbar , Ashish Singh Parihar , Saurabh Kashyap , Amol Joshi , Md Azizur Rahman","doi":"10.1016/j.ipha.2023.12.001","DOIUrl":"10.1016/j.ipha.2023.12.001","url":null,"abstract":"<div><p>The plant species <em>Ziziphus mauritiana</em>, recognized by its common name Indian jujube, is classified within the Rhamnaceae family. It has been widely used in traditional medicine for its therapeutic properties, including the treatment of asthma, anxiety, depression, fever, inflammation, and ulcers. <em>Z. mauritiana</em> parts, such as leaves and fruits, have been traditionally used to treat diarrhea, wounds, abscesses, swelling, gonorrhea, liver diseases, and asthma. <em>Z. mauritiana</em> fruits are widely recognized and valued for their nutritional and nutraceutical properties and are consumed in various forms such as dried, candied, pickled, and juice. The plant exhibits antioxidant activity, and extracts from its fruits, leaves, and seeds have shown promising results in terms of their antioxidant and anticancer activities. Phytochemical studies have identified various compounds in <em>Z. mauritiana</em>, including cyclopeptide alkaloids and lupane and ceanothane triterpenes. This review presents a comprehensive overview of the ethnobotanical uses, traditional medicinal uses, and phytochemical profile of <em>Z. mauritiana</em>, highlighting its potential as a valuable medicinal plant. Further research is warranted to explore its therapeutic potential and develop new pharmaceutical applications based on its bioactive compounds.</p></div>","PeriodicalId":100682,"journal":{"name":"Intelligent Pharmacy","volume":"2 2","pages":"Pages 274-283"},"PeriodicalIF":0.0,"publicationDate":"2023-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2949866X23001272/pdfft?md5=1c690ce8c653b1ffcaea22e8b5b5125b&pid=1-s2.0-S2949866X23001272-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138991181","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}